<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03966807</url>
  </required_header>
  <id_info>
    <org_study_id>IUSCC-0670</org_study_id>
    <nct_id>NCT03966807</nct_id>
  </id_info>
  <brief_title>Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting for Actively Smoking Family Members</brief_title>
  <official_title>Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting as a Potential Teachable Moment for Actively Smoking Family Members</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this pilot study is to examine, in an innovative setting, the potential for a&#xD;
      lung cancer diagnosis in a loved one to represent a teachable moment for smoking cessation in&#xD;
      family members or caregivers who are current smokers. The researchers will identify the&#xD;
      willingness and preferred modality for smoking cessation among family members/caregivers in&#xD;
      this setting. The researchers will estimate abstinence rates at 4, 8, 12, and 24 weeks..&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 19, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>7-day point prevalence of self -reported smoking cessation</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>7-day point prevalence of self -reported smoking cessation</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>7-day point prevalence of self -reported smoking cessation</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>7-day point prevalence of self -reported smoking cessation</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Willingness to quit</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Willingness to quit</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Willingness to quit</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Willingness to quit</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Preference for type of cessation intervention modality</measure>
    <time_frame>4 weeks</time_frame>
    <description>digital versus traditional support with nicotine replacement therapy [NRT]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Preference for type of cessation intervention modality</measure>
    <time_frame>8 weeks</time_frame>
    <description>digital versus traditional support with nicotine replacement therapy [NRT]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Preference for type of cessation intervention modality</measure>
    <time_frame>12 weeks</time_frame>
    <description>digital versus traditional support with nicotine replacement therapy [NRT]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Preference for type of cessation intervention modality</measure>
    <time_frame>24 weeks</time_frame>
    <description>digital versus traditional support with nicotine replacement therapy [NRT]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean change in readiness to quit</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured via the Readiness to Quit Ladder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in readiness to quit</measure>
    <time_frame>4 weeks</time_frame>
    <description>Measured via the Readiness to Quit Ladder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in readiness to quit</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured via the Readiness to Quit Ladder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in readiness to quit</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measured via the Readiness to Quit Ladder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in readiness to quit</measure>
    <time_frame>24 weeks</time_frame>
    <description>Measured via the Readiness to Quit Ladder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in nicotine dependence</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured via the Heaviness of Smoking Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in nicotine dependence</measure>
    <time_frame>4 weeks</time_frame>
    <description>Measured via the Heaviness of Smoking Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in nicotine dependence</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured via the Heaviness of Smoking Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in nicotine dependence</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measured via the Heaviness of Smoking Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in nicotine dependence</measure>
    <time_frame>24 weeks</time_frame>
    <description>Measured via the Heaviness of Smoking Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in cigarette use</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured by by the self-reported number of cigarettes smoked per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in cigarette use</measure>
    <time_frame>4 weeks</time_frame>
    <description>Measured by by the self-reported number of cigarettes smoked per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in cigarette use</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured by by the self-reported number of cigarettes smoked per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in cigarette use</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measured by by the self-reported number of cigarettes smoked per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in cigarette use</measure>
    <time_frame>24 weeks</time_frame>
    <description>Measured by by the self-reported number of cigarettes smoked per day</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Digital-based support</arm_group_label>
    <description>Digital support will consist of referral for the participant to visit https://smokefree.gov, a website which offers a menu of internet- and text-based support options.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>traditional-based support +nicotine replacement therapy(NRT)</arm_group_label>
    <description>Traditional support will consist of participant referral to the Indiana Tobacco Quitline (1-800-QUIT-NOW) which is a telephone hotline that connects participants to Indiana smoking cessation resources.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Digital-based support</intervention_name>
    <description>Digital support will consist of referral for the participant to visit https://smokefree.gov, a website which offers a menu of internet- and text-based support options.</description>
    <arm_group_label>Digital-based support</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Traditional-based support + Nicotine replacement therapy (NRT)</intervention_name>
    <description>Traditional support will consist of participant referral to the Indiana Tobacco Quitline (1-800-QUIT-NOW) which is a telephone hotline that connects participants to Indiana smoking cessation resources.</description>
    <arm_group_label>traditional-based support +nicotine replacement therapy(NRT)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with newly diagnosed lung cancers will be identified from the daily patient lists&#xD;
        at the thoracic oncology clinics at IUSCC, Roudebush VAMC, and Eskenazi. The study&#xD;
        coordinator will screen for newly diagnosed lung cancer patients to identify potential&#xD;
        family member/caregiver study participants.&#xD;
&#xD;
        Patients will be approached and asked whether they have any family members/caregivers who&#xD;
        smoke, and if they would be willing to allow the study team to contact those people (or&#xD;
        person) with information about the study. For patients who agree and have family&#xD;
        members/caregivers present at the clinic visit that day, the study coordinator (or other&#xD;
        designated member of the study team) will discuss the purpose of the study and utilize the&#xD;
        5A strategy (Ask, Advice, Assess willingness to quit, Assist, Arrange follow-up) to&#xD;
        ascertain interest in participation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Patient Inclusion Criteria:&#xD;
&#xD;
          1. patient with newly diagnosed lung cancer within the last 6 months of initial&#xD;
             diagnosis/confirmation of diagnosis at the study sites&#xD;
&#xD;
          2. Able to provide informed consent&#xD;
&#xD;
          3. Able to speak and read English&#xD;
&#xD;
        Family Member/Caregiver Participant Criteria:&#xD;
&#xD;
          1. Family member or caregiver (defined as first degree relative [parent, sibling, child]&#xD;
             or person living in the same household)&#xD;
&#xD;
          2. Family member or caregiver must be a current, active smoker (defined as 10 cigarettes&#xD;
             per day for 6 consecutive months).&#xD;
&#xD;
          3. At least 18 years of age at time of study consent&#xD;
&#xD;
          4. Able to provide informed consent&#xD;
&#xD;
          5. Able to speak and read English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Currently receiving formal tobacco dependence treatment- Nicotine replacement of any&#xD;
             kind, varenicycline or Bupropion.&#xD;
&#xD;
          2. Medical condition that precludes proposed pharmacotherapy for smoking cessation :&#xD;
             Recent (â‰¤ 2 weeks) myocardial infarction , history of underlying arrhythmias , history&#xD;
             of serious or worsening angina pectoris, pregnancy and breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shadia Jalal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ali Ajrouch, MD</last_name>
    <phone>317-274-0338</phone>
    <email>aajrouch@iu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>IU Health Joe and Shelly Schwarz Cancer Center</name>
      <address>
        <city>Carmel</city>
        <state>Indiana</state>
        <zip>46032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Indiana University Melvin &amp; Bren Simon Cancer Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Ajrouch, MD</last_name>
      <phone>317-274-0338</phone>
      <email>aajrouch@iu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Shadia Jalal, MD</last_name>
      <phone>317-274-3589</phone>
      <email>sjalal@iu.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 18, 2019</study_first_submitted>
  <study_first_submitted_qc>May 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 29, 2019</study_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>Shadia Jalal</investigator_full_name>
    <investigator_title>Assistant Professor of Clinical Medicine</investigator_title>
  </responsible_party>
  <keyword>lung cancer</keyword>
  <keyword>caregiver</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

